Abstract:Objectives To compare outcomes and characteristics of two cohorts of patients: those receiving medication abortion (MAB) at ≤42 days gestation and those at 43-56 days gestation. Study Design We conducted a retrospective cohort study to compare characteristics and outcomes of all 142 patients accessing MAB at ≤42 days versus 200 patients at 43-56 days in 2022. We sought to detect a 7% difference in MAB success with 80% power and an alpha of 0.05. We compared follow-up responses and unscheduled contacts with the healthcare system. Results Abortion success rates were similar between the ≤42 day and 43-56 day groups (94.3% vs 97%, p=0.226). Those ≤42 days had a higher frequency of unscheduled office visits (13% vs 6%, p=0.01) but no difference in phone calls or emergency room visits. More patients with successful MAB in the ≤42 days group answered that bleeding (11.7% vs 1.9%, p=0.006) and cramping (10.5% vs 2.9%, p=0.035) were not heavier or worse than a period, and that they did not have pregnancy symptoms prior to the abortion (15.8% vs 6.0%, p=0.034). Patients ≤42 days gestation less often had a pre-treatment ultrasound (48% vs 64%, p=0.004). Patients without prior ultrasound more often needed uterine aspiration to complete the abortion (6.8% vs 2%, p=0.027). Conclusions Patients undergoing MAB at ≤42 days have similar success rates but more unscheduled office visits, and more ambiguous symptoms when using standardized questions for evaluating abortion success. Clinicians should consider adapting their anticipatory guidance and counseling for this population. Implications Access to very early abortion is increasingly relevant as legal restrictions on abortion increase. Earlier gestations may have different responses to standard follow-up questions despite a successful MAB and may have more interactions with the healthcare system.

EP07.24: Sequence of events leading to medical abortion for fetal indications after 34 weeks of gestation: 23‐years experience from a single medical centre

Analysis of Mifeprestone Combine Misoprostol Induced Early Pregnancy Ending after Cesarean Section

Initiating medical abortion in an emergency department in the United States

EP08.21: Prediction of adverse intrapartum outcomes at 35–37 weeks

EP11.06: Uterine rupture suspected in a primigravida with prior adenomyomectomy: a case report at 27 weeks of gestation

EP08.43: Sonographic surveillance and neonatal outcomes among pregnancies with periviable fetal growth restriction

Comparison of medication abortion outcomes at less than and greater than 6 weeks gestation

Abortion medical management between 14-16 weeks' amenorrhea after French legislation deadline extension

Can mid‐level providers manage medical abortion after 12 weeks' gestation as safely and effectively as physicians? A non‐inferiority, randomized controlled trial in Addis Ababa, Ethiopia

Patient experiences of undergoing abortion with and without an ultrasound scan in Britain

EP08.10: Sonographic surveillance and perinatal outcomes among pregnancies with periviable fetal growth restriction

EP10.25: Initiation of fetal therapy at Semmelweis University, Hungary

EP21.02: Location of the gestational sac in pregnancies conceived by assisted reproductive technology

EP07.40: Prenatal diagnosis of malformations of the urinary system: about 24 cases

EP22.37: Partial hydatidiform mole with a coexisting live fetus: a case report

Impact of policy change on late-term abortion: a two-decade analysis

EP06.28: Prenatal diagnosis and outcome of meso/dextrocardio: a single‐centre report of 29 cases

Understanding medication abortion ineligibility due to gestational age among a cohort of patients in Southern California

EP14.28: The outcome of twin pregnancies delivered in a nine‐year period

Outcomes and complications of second-trimester induction of labor using laminaria and gemeprost: A single-center experience in Japan

OC08.08: Fetal descent examined with transabdominal ultrasound